FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass II · Drug · Recalled May 13, 2026

Enalapril Maleate Tablets recall — JB Chemicals and Pharmaceuticals Ltd

Hazard: Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0520-2026
Brand
JB Chemicals and Pharmaceuticals
Classification
Class II
Units affected
675 bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.

Affected products

Companies & origin

Recalling firm location
Mumbai, India
Firm address
Neelam Centre A Wing A B Wing, 4th Floor; Hind Cycle Road, N/A

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: GEH25023, Expires: 6/30/2027
Distribution
Nationwide in the USA
Firm notified the public via
Letter
FDA event ID
98794
Recall initiated
April 23, 2026
FDA classified
May 5, 2026
FDA report date
May 13, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page